Experiments
Searchable full-text extractions: founding hypothesis, core claims, experimental setups, key results and statistics — pulled out of each paper as structure. Search a cell line, an assay or an entity (e.g. HUH7) and find every paper that worked with it. This corpus stands on its own: most entries carry no reproduction assessment (yet).
-
Full-text index only
Distinct molecular and tumor microenvironment characteristics of mucinous adenocarcinoma in colorectal cancer.
PMID 42100746 · PMC13145884 · iScience · 2026 · 8 claims · 8 setups
MAC is associated with significantly worse overall survival than CAC, but only within the MSS subtype
-
Full-text index only
A differential single-cell transcriptome atlas of left-sided and right-sided colorectal cancer.
PMID 41844817 · PMC13111741 · Discover oncology · 2026 · 8 claims · 8 setups
MTRNR2L8 is markedly upregulated in RCRC tumor cells and is associated with poorer patient survival
-
Full-text index only
Single-Cell Sequencing Reveals γδT Cell Heterogeneity Under Distinct Microsatellite Statuses as a Potential Biomarker for Immunotherapy and Prognosis in Colorectal Cancer.
PMID 42074506 · PMC13116210 · Genes · 2026 · 7 claims · 8 setups
γδT cells in colorectal cancer form five distinct subsets (C0_FCER1G, C1_IL7R, C2_CD81, C3_TOP2A, C4_CXCL13) with distinct marker genes and functional states
-
Full-text index only
Multi-Transcriptomic Analysis Reveals That EREG-Driven TME Crosstalk Defines Anti-EGFR Response in Colorectal Cancer.
PMID 42043480 · PMC13115984 · Cancer medicine · 2026 · 8 claims · 8 setups
EGFRI eligibility (defined by left-sidedness, RAS/BRAF wild-type, MSS) stratifies cancer cell transcriptomic characteristics more strongly than sidedness alone.
-
Has reproduction
Fast, accurate, and racially unbiased pan-cancer tumor-only variant calling with tabular machine learning.
PMID 36611079 · PMC9825621 · NPJ precision oncology · 2023 · 8 claims · 8 setups
Tree-based (XGBoost, LightGBM) and deep-learning (TabNet) tabular ML classifiers achieve state-of-the-art somatic vs germline classification in tumor-only WES samples, outperforming PureCN.